{"@type": "dcat:Dataset", "accessLevel": "public", "accrualPeriodicity": "R/P1Y", "bureauCode": ["009:10"], "contactPoint": {"@type": "vcard:Contact", "fn": "Division of Drug Information", "hasEmail": "mailto:druginfo@fda.hhs.gov"}, "description": "Melphalan Hydrochloride is a prescription injectable chemotherapy drug administered intravenously, available in a 50 mg vial strength. It's manufactured by companies like Gland Pharma Limited and Sagent Pharmaceuticals under FDA approval ANDA209826. This information was generated using AI and is provided for informational and research purposes only.", "distribution": [{"@type": "dcat:Distribution", "description": "\n        Access the FDA dataset for Melphalan hydrochloride \u2014 ANDA 203655 submitted by Mylan Institutional LLC\n    ", "downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203655", "mediaType": "text/html", "title": "Melphalan hydrochloride"}], "identifier": "ANDA203655", "issued": "2016-09-16", "keyword": ["drug", "medications", "pharmaceuticals", "prescription-drugs", "public-health"], "landingPage": "https://www.fda.gov/drugs", "license": "https://open.fda.gov/license", "modified": "2025-03-17", "programCode": ["009:002"], "publisher": {"@type": "org:Organization", "name": "U.S. Food and Drug Administration"}, "theme": ["FDA"], "title": "Melphalan hydrochloride"}